Co‐delivery of dendritic cell vaccine and anti‐PD‐1 antibody with cryomicroneedles for combinational immunotherapy

Combinational immunotherapy of dendritic cell (DC) vaccines and anti‐programmed cell death protein 1 antibodies (aPD1) has been regarded as a promising strategy for cancer treatment because it not only induces tumor‐specific T cell immune responses, but also prevents failure of T cell functions by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hao, Wen, Xueyu, Li, Zhiming, Ling, Zhixin, Zheng, Yanting, Xu, Chenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Special Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487323/
https://www.ncbi.nlm.nih.gov/pubmed/37693072
http://dx.doi.org/10.1002/btm2.10457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487323/
https://www.ncbi.nlm.nih.gov/pubmed/37693072
http://dx.doi.org/10.1002/btm2.10457

Ejemplares similares